Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

Business Wire • Apr 30, 2026

BMEZ: Sell, Distributions Down 34% And Undercovered

BlackRock Health Sciences Trust II yields 9.59% but has reduced its monthly payout by 34% to $0.11. BMEZ's NAV and net assets have declined sharply, with net assets dropping 44% over two years and persistent underperformance versus sector peers. Distributions are mostly return of capital (75%), offering tax deferral but eroding investor basis; distribution coverage remains weak at 0.38x.

Seeking Alpha • Mar 22, 2026

Forget Software Stocks: This 8.8% Dividend Is The Real AI Bargain

Wall Street is mired in another panic over AI. And we contrarians are here for it.

Forbes • Mar 4, 2026

BMEZ: Deep Discount Once Again Makes It An Interesting Play

BlackRock Health Sciences Term Trust (BMEZ) now trades at a compelling 12% discount, offering a potential entry for investors seeking relatively volatile healthcare exposure. BMEZ removed its options writing strategy, increasing reliance on capital appreciation from its biotech-tilted, growth-oriented portfolio for both returns and distribution coverage. The fund's distribution was cut from a 12% managed rate to a more sustainable payout level, with payouts primarily reliant on capital gains rather than income.

Seeking Alpha • Jan 4, 2026

6 Dividend Stocks Ready To Benefit From 2026's Rate-Shift Economy

Let's get our 2026 dividend shopping finished ahead of time, shall we?

Forbes • Dec 4, 2025

BMEZ: NAV Decline Continues And Underperforms Peers

BlackRock Health Sciences Term Trust continues to struggle with unsustainable distributions and rapid NAV decline, prompting a maintained Sell rating. BMEZ's high 8.4% yield is not supported by net investment income, leading to persistent NAV erosion and reliance on return of capital. Despite broad healthcare exposure and option strategies, BMEZ underperforms peers like THQ and BME in total return and capital preservation.

Seeking Alpha • Nov 28, 2025

A Dividend Cut Just Created A 9.2% Monthly Dividend Bargain

Most Wall Street “suits” are allergic to dividend cuts. These spreadsheet jockeys sooooo lack imagination.

Forbes • Sep 18, 2025

BlackRock Announces Update to BMEZ, BSTZ, and BTX Managed Distribution Plans

NEW YORK--(BUSINESS WIRE)---- $BMEZ--The Board of Trustees (the "Board") of BlackRock Health Sciences Term Trust (BMEZ), BlackRock Science and Technology Term Trust (BSTZ), and BlackRock Technology and Private Equity Term Trust (BTX) (the “Funds”) approved updates to each Fund's managed distribution plan that will take effect with the October 2025 distribution. The Funds will change from a floating rate distribution to a level rate distribution at the stated monthly rates provided below. These changes se.

Business Wire • Sep 11, 2025

Revisiting BMEZ: Why The Widening Discount Warrants A 'Hold' Rating

BMEZ's discount to NAV has widened back to nearly 10%, making it less of an urgent sell but not yet a buy. The fund's 13.74% distribution rate is appealing, but it is entirely return of capital, raising sustainability concerns. Significant private investments and a high distribution rate may further pressure the discount, especially if distributions are cut.

Seeking Alpha • Sep 8, 2025

5 Closed-End Fund Buys In The Month Of July 2025

With the month of July closing out, we are once again seeing the broader equity markets pushing to new all-time highs. As we enter into new all-time highs, we appear to be looking quite stretched on valuations, and CEF discounts have been narrowing.

Seeking Alpha • Aug 14, 2025